Holly Gwen Prigerson

Weill Cornell Medicine

NIH Rank #2950
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.8M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#2,950
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.8M across 4 grants · National rank #2950.

Top grants by award amount

Holly Gwen Prigerson's NIH grant portfolio, ranked by award amount.

  • 5R35CA197730-10R35
    Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)
    $955.9K
    award amount
  • 1R01NR021159-01A1R01
    Bridge to Better End-of-Life Care for Black Patients with Cancer: Connecting Healthcare Chaplains with Spiritual Care Providers in Faith Communities
    $873K
    award amount
  • 5R01NR019831-03R01
    A Multisite Randomized Controlled Trial of EMPOWER for Family Surrogates of Critically Ill Patients
    $773.6K
    award amount
  • 5R21AG077144-02R21
    The Living Memory Home: Reducing Grief and Improving Relationships between Home-based Patients with ADRD and Their Family Caregivers
    $211.7K
    award amount

Affiliation

Institutions that have administered grants for Holly Gwen Prigerson.

Affiliated with Weill Cornell Medicine (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2950
  6. 2024
    Entered Top 25% Nationally
    Ranked #2950